The information on this page is intended for healthcare professionals. Patient-specific information is available in the “Patients” section of this site. Patients should consult a healthcare professional regarding specific medical conditions and treatments.
Delivering Better Solutions
At Acelity, we recognize that major changes are taking place in our healthcare environment. We deliver solutions which improve the lives of patient and also address real system constraints.
In an environment where difficult trade-offs can be required, Acelity is committed to researching and partnering on the value of our products, with the aim of helping your institution deliver the greatest value to patients.
Proven Clinical & Economic Value Evidence
We are focused on researching and documenting the value of our products - in clinical and economic terms – to deliver on our promise of innovative solutions that improve the lives of patients. Much of our research is aimed to inform policy and decision makers when real trade-offs are necessary by providing a systematic basis to evaluate alternative treatments.
As a unified company, Acelity works to simplify ordering and contracting processes and continues to work with healthcare system partners to deliver tools that streamline the delivery of care.
Reducing the Cost of Care
Our innovative solutions work to help the overall cost of care by focusing on delivering the best outcome for patients in the most cost-efficient way.
Case Study: Reducing Costs in Wound Care
Wound care is central to what we do and an important part of patient care that can affect patient Quality of Life, total cost to treat, and key hospital metrics, and thus help reduce hospital costs. Our research demonstrated that V.A.C.® Therapy for wound care can be an integral part of reducing length of stay, reducing readmission rates and reducing total cost to treat.1,2
1. Analysis conducted on hospital patient level data by Premier Research Services. Data collected from 144 hospitals for KCI, 24 hospitals for Competitor, for the time period July 1, 2011-June 1, 2013. Research funded by KCI. Data on file.
2. Law, A, Cyhaniuk, A, and Krebs, B. Comparison of Health Care Costs and Hospital Readmission Rates Associated With Negative Pressure Wound Therapies WOUNDS 2015;27(3):63-72.
You are leaving myKCI.com
You are now leaving the US KCI website. Links to other sites are provided as a convenience to users. These websites are not affiliated with KCI, and KCI accepts no responsibility for their content.
Copyright 2016,2019, KCI Licensing, Inc. All rights reserved.
The information included in this web site has been prepared for and is intended for viewing by residents of the United States of America. This web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.
The information in the “Products” and “Healthcare Professionals” sections of this website is intended for healthcare professionals. Patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site, including the risks and benefits of certain products and services that may be discussed on this site.